His research showed that Type 2 diabetes was caused by insulin resistance at the cellular level, a controversial idea that ...

A multinational research team led by researchers at Institute of Science Tokyo, RIKEN, and the University of Toronto has ...

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

The FDA granted orphan drug designation to a triggering receptor expressed on myeloid cells 1 peptide inhibitor for the ...

Explore NMDA receptor modulation and its critical role in neuronal development and cognitive functions like learning and memory.

Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license ...

Rendering a drug effective or ineffective in a flash at the appropriate location – this is the focus of research in ...

Additional information about the 2026 AAN Annual Meeting is available at www.aan.com.

One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...

Emcure Pharmaceuticals has reduced the price of its weight management drug Poviztra to ₹3,999 per month, effective 3 April ...

All-cause mortality significantly lower with GLP-1 RA use, with consistent benefit across major cancer types, most GLP-1 RA types.

New Assay Expands INDIGO’s GPCR Portfolio and Supports Development of Next-Generation CNS-Related Therapeutics STATE ...